Executives pulled back on a 2030 sales target of $11 billion as demand for the HPV shot shrinks amid China market turmoil.

Robert F. Kennedy Jr. has cleared his first hurdle to become the nation’s top health official as the Senate finance committee ...

Two U.S. senators who will vote this week on whether to advance Robert F. Kennedy Jr.'s nomination as the top U.S. health ...

Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...

Senator Bill Cassidy, MD (R-LA), voted “yes” today to advance Robert F. Kennedy Jr.’s nomination to be Secretary of the ...